Article open access publication

Clinical Goals and Barriers to Effective Psoriasis Care

Dermatology and Therapy, Springer Nature, ISSN 2190-9172

Volume 9, 1, 2019

DOI:10.1007/s13555-018-0279-5, Dimensions: pub.1110821912, PMC: PMC6380974, PMID: 30578464,

Affiliations

Organisations

  1. (1) Probity Medical Research, grid.415267.3
  2. (2) University of Connecticut Health Center, grid.208078.5
  3. (3) International Psoriasis Council, St. Louis, MO, USA
  4. (4) University of Southern California, grid.42505.36
  5. (5) Université de Sherbrooke, grid.86715.3d
  6. (6) Moinhos de Vento Hospital Complex, Porto Alegre, Brazil
  7. (7) University of Buenos Aires, grid.7345.5
  8. (8) Ben-Gurion University of the Negev, grid.7489.2
  9. (9) Clalit Health Services, grid.414553.2
  10. (10) ClĂ­nica Dermacross, Santiago, Chile
  11. (11) University of Michigan, grid.214458.e
  12. (12) Cardiff University, grid.5600.3
  13. (13) Icahn School of Medicine at Mount Sinai, grid.59734.3c
  14. (14) Aarhus University Hospital, grid.154185.c, Central Denmark Region
  15. (15) Manchester Academic Health Science Centre, grid.462482.e
  16. (16) Saint Louis University, grid.262962.b
  17. (17) University of Toronto, grid.17063.33
  18. (18) University College Dublin, grid.7886.1
  19. (19) National Skin Centre, grid.410763.7
  20. (20) University of Chile, grid.443909.3
  21. (21) Dermatrials Research, grid.477226.2
  22. (22) Dermatology Research and Education Foundation, Irvine, CA, USA
  23. (23) Beth Israel Deaconess Medical Center, grid.239395.7

Description

Engaging global key opinion leaders, the International Psoriasis Council (IPC) held a day-long roundtable discussion with the primary purpose to discuss the treatment goals of psoriasis patients and worldwide barriers to optimal care. Setting clear expectations might ultimately encourage undertreated psoriasis patients to seek care in an era in which great gains in therapeutic efficacy have been achieved. Here, we discuss the option for early treatment of all categories of psoriasis to alleviate disease impact while emphasizing the need for more focused attention for psoriasis patients with mild and moderate forms of this autoimmune disease. In addition, we encourage policy changes to keep pace with the innovative therapies and clinical science and highlight the demand for greater understanding of treatment barriers in resource-poor countries.

Research Categories

Main Subject Area

Fields of Research

Links & Metrics

NORA University Profiles

Aarhus University

Dimensions Citation Indicators

Times Cited: 14

Open Access Info

Pure Gold